Immunome, Inc. (IMNM)
21.84
-0.61
(-2.72%)
USD |
NASDAQ |
Apr 02, 16:00
21.95
+0.11
(+0.50%)
After-Hours: 20:00
Immunome Total Assets (Quarterly) : 683.19M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.334B |
| Scholar Rock Holding Corp. | 404.27M |
| Stoke Therapeutics, Inc. | 418.43M |
| Nurix Therapeutics, Inc. | 702.56M |
| CytomX Therapeutics, Inc. | 152.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.84M |
| Shareholders Equity (Quarterly) | 634.34M |
| Debt to Equity Ratio | 0.0061 |
| Current Ratio | 14.69 |
| Net Debt Paydown Yield | -0.01% |